Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-controlled, Double-blind, Randomized, Single Dose, Dose Escalating Trial in Healthy Men to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPC3649

NCT00688012 is registered in ClinicalTrials.gov with Santaris Pharma A/S as lead sponsor.

NCT NCT00688012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00688012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-controlled, Double-blind, Randomized, Single Dose, Dose Escalating Trial in Healthy Men to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPC3649
Lead sponsor
Santaris Pharma A/S
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2008
Completion date
May 31, 2009
Enrollment
64
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c